Divided into groups, we observed that in the AML-MR group with a worse prognosis, 12 of the 13 missense mutations predicted to exhibit decreased p53 protein stability change, two frameshifts, and two stop codon mutations were detected. This evidence concerns the gene TP53 and acute myeloid leukemia.